Parkinson’s Disease

Parkinson´s disease is a progressive neurodegenerative disorder.

The unique features of Infudopa™

Our products in development

“I have an ethical responsibility to contribute to Infudopa becoming available to patients suffering from Parkinson’s disease”

– Arvid Carlsson (1923-2018) who received the Nobel prize in 2000 for the discoveries that paved the way for the introduction of levodopa as treatment for Parkinson´s disease.

Dizlin Pharmaceuticals receives patent approval in the USA

Gothenburg, Sweden, April 25th, 2023 – Dizlin Pharmaceuticals AB, a research-based pharmaceutical development company with focus on diseases of the central nervous system (CNS), today announces a patent approval in the USA Dizlin Pharmaceuticals has [...]

CEO Letter, December 2022

Dizlin has during the autumn continued to work on prioritized projects according to the updated project plan. Progress has been made with pharmaceutical development, pump development and the regulatory application process.   The extensive work with [...]

Read all news
Go to Top